Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction
Open Access
- 1 September 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (38) , 35509-35515
- https://doi.org/10.1074/jbc.m205477200
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Clonal Heterogeneity in Telomerase Activity and Telomere Length in Tumor-Derived Cell LinesProceedings of the Society for Experimental Biology and Medicine, 2000
- Subsenescent Telomere Lengths in Fibroblasts Immortalized by Limiting Amounts of TelomeraseJournal of Biological Chemistry, 2000
- Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugsOncogene, 1999
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999
- Requirement for p53 and p21 to Sustain G 2 Arrest After DNA DamageScience, 1998
- Extension of Life-Span by Introduction of Telomerase into Normal Human CellsScience, 1998
- Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRTNature Genetics, 1997
- Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signalsCell, 1995
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- Telomeres shorten during ageing of human fibroblastsNature, 1990